In October, a crane carefully lowered the University of Ottawa Heart Institute’s first dedicated magnetic resonance imaging (MRI) scanner into a narrow access way so that it could be rolled through the exterior wall of the building and into position. By early December, the new MRI facility was fully

Heart disease is different for women, and that difference is borne out in almost every aspect of the disease: the factors that lead to it, symptoms, diagnosis, treatment and even risk of death. In fact, heart disease kills more women worldwide than all cancers, tuberculosis, AIDS and malaria

Cardiovascular prevention and rehabilitation underwent extensive change in the 20th century and continues to evolve rapidly. Andrew Pipe, MD, in his Terry Kavanagh Lecture at the 2014 Canadian Cardiovascular Congress, outlined a vision for "CVD Prevention and Rehabilitation in the 21st Century." To

While modern medicine is heavily dependent on sophisticated technologies to diagnose and treat disease, health care generally lags behind other sectors in adopting advances in information technology. A number of presentations at the 2014 Canadian Cardiovascular Congress looked at ways in which

More than half a million Canadians are living with heart failure and another 50,000 join their ranks each year. The standard treatment for heart failure has not changed for quite some time. Now, a new drug—so new that it’s identified only as LCZ696—is generating interest among cardiologists and

Until the new oral anticoagulant (NOAC) drugs became available, beginning in 2009, warfarin was the workhorse for managing stroke risk in patients with atrial fibrillation. In his Research Achievement Award presentation, Stuart Connolly, MD, of McMaster University in Hamilton, Ont., provided a